AGVHD
Clinical trials for AGVHD explained in plain language.
Never miss a new study
Get alerted when new AGVHD trials appear
Sign up with your email to follow new studies for AGVHD, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Double donor transplant trial aims to boost survival in blood cancer patients
Disease control Recruiting nowThis study tests whether using stem cells from both a half-matched family donor and a cord blood donor can improve survival without cancer returning. It is for people with certain high-risk blood cancers like leukemia or myelodysplastic syndromes. The approach aims to control the…
Matched conditions: AGVHD
Phase 2 • Sponsor: Case Comprehensive Cancer Center • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
Switching stomach drugs after transplant may tame a deadly immune attack
Disease control Recruiting nowThis trial tests whether changing from acid-blocking drugs to a stomach-lining protector called teprenone after a stem cell transplant can reduce the risk of acute graft-versus-host disease (aGVHD), a serious complication where donor immune cells attack the recipient's body. Abou…
Matched conditions: AGVHD
Sponsor: First Affiliated Hospital of Zhejiang University • Aim: Disease control
Last updated Aug 30, 2026 00:00 UTC
-
New drug aims to stop immune attack after stem cell transplants
Disease control Recruiting nowThis study tests a drug called BPC2001 to prevent acute graft-versus-host disease (aGVHD), a serious complication where donor immune cells attack the patient's body after a stem cell transplant. Fifty adults with blood cancers like leukemia will receive six weekly doses of BPC200…
Matched conditions: AGVHD
Phase 2 • Sponsor: BioPhoenix Co., Ltd. • Aim: Disease control
Last updated Aug 19, 2026 00:00 UTC